Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 3,761–3,780 of 17,937 drug recalls

Drug Recall Terminated Historical recordClass II

Cefazolin for injection USP, and Dextrose Injection, USP, 2 g, 50 mL duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3105-11

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Cefazolin for injection USP, and Dextrose Injection, USP, 1G, 50 ML duplex container, Rx only, MFG: B. Braun Medical Inc., NDC 0264-3103-11

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Diprivan (Propofol) Emulsion, 200 mg per 20 mL (10mg/mL), 20 mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-29

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Diprivan (Propofol) Emulsion, 100 mg/mL, 10mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-10

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Ofloxacin Otic Solution 0.3%, 5 mL bottle, Rx only, MFG: Amneal/Akyma Pharmaceuticals, NDC 69238-1615-3

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Tetracaine Hydrochloride Ophthalmic Solution, 0.5%, 4 mL bottle, Rx only, MFG: Alcon Surgical Inc., NDC 0065-0741-14

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Geodon for injection (ziprasidone mesylate), 20 mg/mL, 1 mL single dose vial, Rx only, MFG: Viatris, NDC 0049-3920-83

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Sumatriptan Succinate Tablets, 100 mg, 9 (1 x 9) Unit-of- use tablets box, Rx only, MFG: Sun Pharmaceuticals, NDC 62756-522-69

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Metoprolol tablets 50 mg, 100-count botte, Rx only, MFG: Sun Pharmaceuticals, NDC 57664-0477-52

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Pilocarpine HCL Ophthalmic Solution, USP 2%, 15 mL, Rx only, MFG: Somerset Therapeutics, Inc., NDC 7006919101

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Tropicamide Ophthalmic Solution, USP 1%, 3 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 6131435502

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution, USP, sterile, 0.1%, 10 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 6131462810

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Triamcinolone Acetonide cream, USP, 0.1% ,15 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0004-15

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Prednisolone Acetate Ophthalmic Suspension, USP 1%, 5 mL bottle, Rx only, MFG: Sandoz Pharma, NDC 61314-637-05

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Pantoprazole Sodium for Injection, 40 mg/vial, 10 single-dose vials, Rx only, MFG: Sandoz Pharma, NDC 0781-3232-95

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Ondansetron HCL, Tab 8 mg filmcoated, 30-count bottle, Rx only, MFG: Sandoz Pharma, NDC 65862-188-30

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment, 3.5 g tube, Rx only MFG: Sandoz, NDC 61314-631-36

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Diphenhydramine HCl oral solution, USP, 25 mg/10 mL UD, packaged in a) 10 mL unit dose cups (NDC 0121-0978-10), b) 100-count box (NDC 0121-0978-00), Rx only, MFG: Pharmaceutical Associates Inc.

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Verapamil HCL, ampule, 2.5 mg/ML 2ML (5/pack), Rx only, MFG: Pfizer, NDC 04094-011-01

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Thrombin JMI, Vial 5,000IU 2/diluent, kit, Rx only, MFG: Pfizer NDC 60793-215-05

by Mckesson Medical-Surgical Inc. Corporate Office

Reason
cGMP deviations: Temperature abuse
Recall initiated
April 13, 2022
Reported by FDA
June 15, 2022
Distribution
USA nationwide.

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.